XGX 001Alternative Names: XGX-001
Latest Information Update: 08 Jul 2016
At a glance
- Originator Xeragenx Plant Sciences
- Class Proteins; Vitamin B12 analogues
- Mechanism of Action Vitamin B12 receptor protein agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Vitamin B deficiency
Most Recent Events
- 08 Jul 2016 Early research in Vitamin B deficiency in USA (PO)